Germany's Genomatix strong in Japan: licenses to Pfizer Japan Inc., Ono Pharmaceuticals

18-Aug-2004

Genomatix attributes the rising interest to its record of scientific innovation in the analysis of gene regulation. With the recent licensing of GenomatixSuite to Pfizer Inc. in Japan, and the signup of Ono Pharmaceuticals, Genomatix further expands its strong customer base in Japan.

GenomatixSuite contains databases and analysis tools centered on gene regulatory networks and pathways and contains the largest available database of real mammalian promoter DNA sequences. It is used by more than 17,000 researchers worldwide.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...